ArticleOpen forum infectious diseases2024

Who to Boost When: The Effect of Age and Dosing Interval on Delta and Omicron COVID-19 Incidence in the Open-label Phase of the COVE Trial.

Dean Follmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.